Matthew Rousculp
Vice President of Novavax.
Articles
Novavax COVID-19 Vaccine Linked to Fewer Side Effects in Health Care Workers and First Responders
April 28th 2025At ESCMID 2025, SHIELD study data show Novavax recipients experienced fewer side effects and missed less work compared to those who received the Pfizer-BioNTech COVID-19 vaccine.
Read More
Latest Updated Articles
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: April 25th 2025 | Updated: April 29th 2025
FDA Requests Additional Trial of Novavax NVX-CoV2601 Vaccine Prior to Approval
Published: April 23rd 2025 | Updated: April 29th 2025
Next-Generation Antivirals Outperform Paxlovid in Preclinical Coronavirus Testing
Published: April 21st 2025 | Updated: April 29th 2025
The Impact of the Pandemic on Antimicrobial Resistance
Published: April 23rd 2025 | Updated: April 23rd 2025
CDC Reports 800 Confirmed Measles Cases Across the US, 624 Being in Texas
Published: April 23rd 2025 | Updated: April 29th 2025
Working to Prevent Malaria Through Genomic Research, Education
